Diane Kadidlo

1.2k total citations
22 papers, 952 citations indexed

About

Diane Kadidlo is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Diane Kadidlo has authored 22 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Hematology and 9 papers in Immunology. Recurrent topics in Diane Kadidlo's work include Hematopoietic Stem Cell Transplantation (12 papers), CAR-T cell therapy research (10 papers) and Immune Cell Function and Interaction (9 papers). Diane Kadidlo is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), CAR-T cell therapy research (10 papers) and Immune Cell Function and Interaction (9 papers). Diane Kadidlo collaborates with scholars based in United States, United Kingdom and Qatar. Diane Kadidlo's co-authors include David H. McKenna, Jeffrey McCullough, Darin Sumstad, John E. Wagner, Jeffrey S. Miller, Keli L. Hippen, Bruce R. Blazar, Annette Sauer‐Heilborn, Sarah C. Merkel and James L. Riley and has published in prestigious journals such as Blood, Science Translational Medicine and American Heart Journal.

In The Last Decade

Diane Kadidlo

20 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane Kadidlo United States 15 505 346 333 229 159 22 952
Kimberly L. Gandy United States 13 285 0.6× 238 0.7× 117 0.4× 138 0.6× 156 1.0× 32 790
Mattia Algeri Italy 16 210 0.4× 294 0.8× 225 0.7× 131 0.6× 66 0.4× 55 685
Tom Erkers Sweden 16 296 0.6× 216 0.6× 126 0.4× 293 1.3× 130 0.8× 30 753
Pilar Hernández-Campo Spain 12 300 0.6× 435 1.3× 127 0.4× 191 0.8× 91 0.6× 16 889
Elaine Herer Canada 11 240 0.5× 136 0.4× 185 0.6× 203 0.9× 129 0.8× 19 856
Hande H. Tuncer United States 8 243 0.5× 155 0.4× 200 0.6× 205 0.9× 116 0.7× 16 552
Valérie Lapierre France 15 278 0.6× 236 0.7× 132 0.4× 77 0.3× 64 0.4× 22 855
Pierre Teira Canada 14 112 0.2× 200 0.6× 214 0.6× 222 1.0× 85 0.5× 43 725
Katherine H. Miller United States 8 397 0.8× 500 1.4× 103 0.3× 95 0.4× 62 0.4× 13 841
Mike Keeney Canada 8 173 0.3× 205 0.6× 153 0.5× 164 0.7× 65 0.4× 13 516

Countries citing papers authored by Diane Kadidlo

Since Specialization
Citations

This map shows the geographic impact of Diane Kadidlo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Kadidlo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Kadidlo more than expected).

Fields of papers citing papers by Diane Kadidlo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Kadidlo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Kadidlo. The network helps show where Diane Kadidlo may publish in the future.

Co-authorship network of co-authors of Diane Kadidlo

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Kadidlo. A scholar is included among the top collaborators of Diane Kadidlo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Kadidlo. Diane Kadidlo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Johnson, Matthew J., Darin Sumstad, Timothy D. Folsom, et al.. (2025). Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancers. Cytotherapy. 27(10). 1229–1239.
3.
MacMillan, Margaret L., Keli L. Hippen, David H. McKenna, et al.. (2021). First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings. Blood Advances. 5(5). 1425–1436. 54 indexed citations
4.
Sumstad, Darin, Diane Kadidlo, Julie Curtsinger, et al.. (2018). Clinical‐scale production of cGMP compliant CD3/CD19 cell‐depleted NK cells in the evolution of NK cell immunotherapy at a single institution. Transfusion. 58(6). 1458–1467. 20 indexed citations
5.
McKenna, David H., Darin Sumstad, Diane Kadidlo, et al.. (2016). Optimization of cGMP purification and expansion of umbilical cord blood–derived T-regulatory cells in support of first-in-human clinical trials. Cytotherapy. 19(2). 250–262. 37 indexed citations
6.
Pollock, Kathryn, Darin Sumstad, Diane Kadidlo, David H. McKenna, & Allison Hubel. (2014). Clinical mesenchymal stromal cell products undergo functional changes in response to freezing. Cytotherapy. 17(1). 38–45. 48 indexed citations
7.
8.
McKenna, David H., Diane Kadidlo, Sarah Cooley, & Jeffrey S. Miller. (2012). Clinical Production and Therapeutic Applications of Alloreactive Natural Killer Cells. Methods in molecular biology. 882. 491–507. 10 indexed citations
9.
Koepsell, Scott A., Diane Kadidlo, Susan K. Fautsch, et al.. (2012). Successful “in‐flight” activation of natural killer cells during long‐distance shipping. Transfusion. 53(2). 398–403. 15 indexed citations
10.
Klingemann, Hans, Elliott C. Cutler, Diane Kadidlo, et al.. (2012). Autologous stem cell transplant recipients tolerate haploidentical related‐donor natural killer cell–enriched infusions. Transfusion. 53(2). 412–418. 36 indexed citations
11.
Traverse, Jay H., David H. McKenna, Rachel Olson, et al.. (2010). Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction. American Heart Journal. 160(3). 428–434. 70 indexed citations
12.
Whiteside, Theresa L., Deborah Griffin, Joanna Stanson, et al.. (2010). Shipping of therapeutic somatic cell products. Cytotherapy. 13(2). 201–213. 15 indexed citations
13.
McKenna, David H., Darin Sumstad, Diane Kadidlo, et al.. (2010). CD34+ cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine. Cytotherapy. 12(2). 170–177. 6 indexed citations
14.
McKenna, David H., Darin Sumstad, Diane Kadidlo, et al.. (2007). Good manufacturing practices production of natural killer cells for immunotherapy: a six‐year single‐institution experience. Transfusion. 47(3). 520–528. 93 indexed citations
15.
Klein, Mark, Diane Kadidlo, Jeffrey McCullough, David H. McKenna, & Linda J. Burns. (2006). Microbial Contamination of Hematopoietic Stem Cell Products: Incidence and Clinical Sequelae. Biology of Blood and Marrow Transplantation. 12(11). 1142–1149. 48 indexed citations
16.
McCullough, Jeffrey, et al.. (2005). Issues in the quality of umbilical cord blood stem cells for transplantation. Transfusion. 45(6). 832–841. 41 indexed citations
17.
McKenna, David H., Diane Kadidlo, Jeffrey S. Miller, et al.. (2005). The Minnesota Molecular and Cellular Therapeutics Facility: A State-of-the-Art Biotherapeutics Engineering Laboratory. Transfusion Medicine Reviews. 19(3). 217–228. 12 indexed citations
18.
Laroche, Vinçent, et al.. (2005). Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples. Transfusion. 45(12). 1909–1916. 76 indexed citations
19.
Sauer‐Heilborn, Annette, Diane Kadidlo, & Jeffrey McCullough. (2004). Patient care during infusion of hematopoietic progenitor cells. Transfusion. 44(6). 907–916. 65 indexed citations
20.
Burger, Scott R., et al.. (2003). Cellular Engineering of HSV-tk Transduced, Expanded T Lymphocytes for Graft-versus-Host Disease Management. Acta Haematologica. 110(2-3). 121–131. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberly L. Gandy Breakdown of academic impact, for papers by Mattia Algeri Breakdown of academic impact, for papers by Tom Erkers Breakdown of academic impact, for papers by Pilar Hernández-Campo Breakdown of academic impact, for papers by Elaine Herer Breakdown of academic impact, for papers by Hande H. Tuncer Breakdown of academic impact, for papers by Valérie Lapierre Breakdown of academic impact, for papers by Pierre Teira Breakdown of academic impact, for papers by Katherine H. Miller Breakdown of academic impact, for papers by Mike Keeney
Rankless by CCL
2026